Skip to main content

Want a detailed portfolio tracker?

Insight Molecular Diagnostics (IMDX) Earnings (2015 - 2026)

Insight Molecular Diagnostics (IMDX) earnings from Mar 31, 2015 to Mar 31, 2026. The TTM Insight Molecular Diagnostics (IMDX) earnings is -$48M. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Annual Earnings

Quarterly Earnings

Insight Molecular Diagnostics (IMDX) Earnings CAGR table

PeriodCAGR
1 Year TTM-17.82%
3 Years TTM-7.06%
5 Years TTM+12.86%
10 Years TTM+16.60%
All Time TTM+16.60%

Annual Earnings change of Insight Molecular Diagnostics (IMDX)

YearEarningsChange
2026-$4.29M-91.46%
2025-$50M-17.21%
2024-$61M+118.36%
2023-$28M-61.89%
2022-$73M+13.73%
2021-$64M+114.17%
2020-$30M+33.44%
2019-$22M+42.41%
2018-$16M-18.69%
2017-$19M+73.41%
2016-$11M+27.95%
2015-$8.73M+74.95%
2014-$4.99MN/A

Comparison Insight Molecular Diagnostics (IMDX) five years earnings CAGR with competitors

Insight Molecular Diagnostics (IMDX) five years earnings CAGR is 12.87%.

TickerNamefive years Earnings CAGRUpside
NOTVInotiv, Inc. Common Stock105.11%+716.84%
PRPHProPhase Labs Inc91.63%+612.08%
IQVIQVIA Holdings Inc27.63%+114.71%
MEDPMedpace Holdings Inc23.58%+83.25%
ISPCiSpecimen Inc17.65%+37.20%
PSNLPersonalis Inc16.49%+28.15%
BNRBurning Rock Biotech Ltd15.43%+19.91%
WATWaters Corp15.32%+19.04%
IDXXIdexx Laboratories Inc10.19%-20.81%
AAgilent Technologies Inc8.86%-31.16%
MTDMettler-Toledo International Inc8.29%-35.58%
MYNZMainz Biomed N.V.6.76%-47.49%
GHGuardant Health Inc6.12%-52.40%
MDXHMDxHealth SA4.58%-64.44%
XGNExagen Inc3.92%-69.57%
QGENQiagen NV3.42%-73.45%